The pharmaceutical sector is witnessing a major shift in blood sugar therapy with the introduction of GLP-1 transdermal devices. These innovative delivery systems offer a possibly simple alternative to subcutaneous https://anniexrlj416757.qodsblog.com/41112889/glp-1-patches-a-new-approach-to-glucose-control